
    
      Using production-scale platform, this study will carry out whole exome sequencing from
      archival (FFPE) material to Identification and classification of significantly mutated genes,
      determine the somatic genomic alterations that may be relevant to the development or
      treatment of cancer, establish classification of IPNBs gene mutation signature. Next,
      analysis of gene mutation signature and IPNBs clinicopathologic outcomes, including the
      association between pathologic type, long-term oncological outcomes and gene mutation
      signature. Last, the determination of involved signal pathways at IPNB patients.
    
  